Nu Skin Enterprises, Inc.
NUS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $602 | $395 | $361 | $343 |
| - Cash | $252 | $264 | $204 | $187 |
| + Debt | $291 | $311 | $301 | $478 |
| Enterprise Value | $642 | $442 | $458 | $634 |
| Revenue | $364 | $386 | $364 | $446 |
| % Growth | -5.7% | 5.9% | -18.2% | – |
| Gross Profit | $257 | $266 | $247 | $279 |
| % Margin | 70.5% | 68.8% | 67.8% | 62.7% |
| EBITDA | $32 | $43 | $152 | -$35 |
| % Margin | 8.8% | 11.1% | 41.7% | -8% |
| Net Income | $17 | $21 | $108 | -$36 |
| % Margin | 4.7% | 5.5% | 29.5% | -8.1% |
| EPS Diluted | 0.34 | 0.43 | 2.14 | -0.73 |
| % Growth | -20.9% | -79.9% | 393.2% | – |
| Operating Cash Flow | $27 | $36 | $0 | $26 |
| Capital Expenditures | -$10 | -$0 | -$14 | -$13 |
| Free Cash Flow | $18 | $36 | -$13 | $13 |